Literature DB >> 2467820

Triggering of the alternative pathway of human T cell activation involves members of the T 200 family of glycoproteins.

B Schraven1, M Roux, B Hutmacher, S C Meuer.   

Abstract

The present report describes functional characteristics of a monoclonal antibody (mAb), TA/211, which is reactive with a common determinant of the human CD45 molecules. When added to purified testing human T cells, TA/211, which is itself not mitogenic, leads to a strong proliferative response in combination with submitogenic concentrations of anti-T11(2) plus anti-T11(3) mAb. Interestingly, while amplifying anti-CD2-mediated immune responses, T cell activation induced through triggering of the CD3 molecule is not enhanced by TA/211, indicating that the triggering signal provided through CD45 is restricted to alternative pathway activation. Employing T cell subsets negatively selected for the expression of CD45R molecules defined by the mAb anti-2H4 or UCHL1, respectively, it is demonstrated that resting T cells expressing the 2H4 molecules proliferate much stronger to TA/211 than the UCHL1+ T cell subset. Together with the finding that the 2H4+ T cell subset can be activated by the concomitant binding of anti-CD2 antibodies plus anti-2H4, these data strongly suggest that the high molecular weight species of CD45 expressed by unprimed T cells are themselves involved in T cell activation via the alternative pathway.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2467820     DOI: 10.1002/eji.1830190226

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  14 in total

Review 1.  Isoforms of the CD45 common leukocyte antigen family: markers for human T-cell differentiation.

Authors:  L T Clement
Journal:  J Clin Immunol       Date:  1992-01       Impact factor: 8.317

Review 2.  Regulation of cell signaling by the protein tyrosine phosphatases, CD45 and SHP-1.

Authors:  T Ulyanova; J Blasioli; M L Thomas
Journal:  Immunol Res       Date:  1997-02       Impact factor: 2.829

3.  Phenotypic changes associated with activation of CD45RA+ and CD45RO+ T cells.

Authors:  D L Wallace; P C Beverley
Journal:  Immunology       Date:  1990-03       Impact factor: 7.397

4.  T cells of the human intestinal lamina propria are high producers of interleukin-10.

Authors:  J Braunstein; L Qiao; F Autschbach; G Schürmann; S Meuer
Journal:  Gut       Date:  1997-08       Impact factor: 23.059

5.  The transmembrane adaptor protein TRIM regulates T cell receptor (TCR) expression and TCR-mediated signaling via an association with the TCR zeta chain.

Authors:  H Kirchgessner; J Dietrich; J Scherer; P Isomäki; V Korinek; I Hilgert; E Bruyns; A Leo; A P Cope; B Schraven
Journal:  J Exp Med       Date:  2001-06-04       Impact factor: 14.307

6.  Stoichiometry and intracellular fate of TRIM-containing TCR complexes.

Authors:  Mahima Swamy; Gabrielle M Siegers; Gina J Fiala; Eszter Molnar; Elaine P Dopfer; Paul Fisch; Burkhart Schraven; Wolfgang Wa Schamel
Journal:  Cell Commun Signal       Date:  2010-03-18       Impact factor: 5.712

7.  Defective CD2 T cell pathway activation in common variable immunodeficiency (CVID).

Authors:  S Zielen; T J Dengler; P Bauscher; S C Meuer
Journal:  Clin Exp Immunol       Date:  1994-05       Impact factor: 4.330

8.  Carbohydrate specificity of IgM autoantibodies to CD45 in systemic lupus erythematosus.

Authors:  P D Fernsten; J K Czyzyk; T Mimura; J B Winfield
Journal:  Mol Biol Rep       Date:  1994       Impact factor: 2.316

9.  Intimate association of Thy-1 and the T-cell antigen receptor with the CD45 tyrosine phosphatase.

Authors:  S Volarević; C M Burns; J J Sussman; J D Ashwell
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

10.  CD8+ T-cell subsets defined by expression of CD45 isoforms differ in their capacity to produce IL-2, IFN-gamma and TNF-beta.

Authors:  D Adamthwaite; M A Cooley
Journal:  Immunology       Date:  1994-02       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.